Mereo BioPharma (MREO) EPS (Diluted) (2019 - 2026)
Mereo BioPharma (MREO) EPS (Diluted) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | -0.06 |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | -0.72 |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 0.15 |
| 10 | Mereo BioPharma | 47.88 Mn | 47.88 Mn | - | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2019 | -0.27 |